Moreover, these changes endow ADI1-upregulated cells with migratory and invasion capabilities, encompassing the invasive growth mode of the primary tumour and shifting it into a biologically aggressive state that leads to poor outcomes for EC patients. The gene discussed is ADI1; the disease is neoplasm.